News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Tanya Gupta, MD

Tanya Gupta, MD

Tanya Gupta, MD

Articles by Tanya Gupta, MD

Tanya Gupta, MD

Dr Gupta on Considerations for Frontline Treatment Selection in HR+/HER2-Negative Breast Cancer

ByTanya Gupta, MD

April 1st 2025

Tanya Gupta, MD, shares factors informing frontline treatment approaches for metastatic hormone receptor–positive, HER2-negative breast cancer.

Latest Updated Articles

Dr Gupta on Considerations for Frontline Treatment Selection in HR+/HER2-Negative Breast Cancer
April 1st 2025

Trending on OncLive

Venetoclax/Ibrutinib Clears Resistance Mutations in BTK Inhibitor–Resistant CLL

Sacituzumab Govitecan Approved in Europe for First-Line PD-L1 Inhibitor–Ineligible TNBC

Sigvotatug Vedotin Fails to Improve OS in Advanced, Pretreated Nonsquamous NSCLC

NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm

Allogeneic BCMA CAR T-Cell Therapy CT0596 Elicits 100% ORR in R/R Myeloma and Plasma Cell Leukemia